Spyre Therapeutics, Inc. (SYRE) (CIK 0001636282) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001628280-26-011614
- Form
- CORRESP
- Filer
- Spyre Therapeutics, Inc. (SYRE) (CIK 0001636282)
- CIK
- 0001636282
- Ticker
- SYRE
- Filed
- 2026-02-25
- SIC industry
- 2834
- HQ
- Waltham, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1636282/000162828026011614/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer